Citation: Li N, Lu J, Willars GB (2012) Allosteric Modulation of the Activity of the Glucagon-like Peptide-1 (GLP-1) Metabolite GLP-1 936 Amide at the GLP-1 Receptor
, Lu, T
Zhuo M, DAndrea E, Paik JM, Wexler DJ, Everett BM, Glynn RJ, et al
Zoe Lees, PhD, a behavioral health researcher who studies the impact of these drugs on hormone balance, metabolism, and psychological health
Clinical Risk Factors and Evaluation Framework Before starting any GLP-1 medication, your provider should assess personal history of pancreatitis, inflammatory bowel disease, severe gastroparesis, chronic diarrhea, and family history of medullary thyroid carcinoma
PMID: 34494925